|
J Biol Chem, Vol. 275, Issue 9, 6651-6656, March 3, 2000
Ionizing Radiation Exposure Results in Up-regulation of Ku70 via
a p53/Ataxia-Telangiectasia-mutated Protein-dependent
Mechanism*
Kevin D.
Brown §¶,
Tamara A.
Lataxes ,
Sanjeev
Shangary ,
Jennifer L.
Mannino ,
Jason F.
Giardina ,
Jiandong
Chen§** , and
R.
Baskaran
From the Department of Biochemistry and Molecular
Biology, the ** Department of Microbiology, Immunology, and
Parasitology, and the § Stanley S. Scott Cancer Center,
Louisiana State University Medical Center, New Orleans, Louisiana
70112, and the Department of Molecular Genetics and
Biochemistry, University of Pittsburgh Medical Center,
Pittsburgh, Pennsylvania 15261
 |
ABSTRACT |
Genome damaging events, such as -irradiation
exposure, result in the induction of pathways that activate DNA repair
mechanisms, halt cell cycle progression, and/or trigger apoptosis. We
have investigated the effects of -irradiation on cellular levels of the Ku autoantigens. Ku70 and Ku80 have been shown to form a
heterodimeric complex that can bind tightly to free DNA ends and
activate the protein kinase DNA-PKcs. We have found that irradiation
results in an up-regulation of cellular levels of Ku70, but not Ku80, and that this enhanced level of Ku70 accumulates within the nucleus. Further, we uncovered that the postirradiation up-regulation of Ku70
utilizes a mechanism that is dependent on both p53 and damage response
protein kinase ATM (ataxia-telangiectasia-mutated); however, the
activation of DNA-PK does not require Ku70 up-regulation. These
findings suggest that Ku70 up-regulation provides the cell with a means
of assuring either proper DNA repair or an appropriate response to DNA
damage independent of DNA-PKcs activation.
 |
INTRODUCTION |
Ionizing radiation (IR)1
exposure results in oxidative damage to DNA, one of the outcome of
which is introduction of double strand breaks (DSBs) within the genome.
Such genotoxic events activate a number of signaling pathways that
serve, for example, to activate DNA repair mechanisms, halt cell cycle
progression, and/or trigger advancement into apoptosis. These damage
response pathways exist to facilitate genome repair and limit the
accumulation of heritable genetic errors. Not surprisingly, a wide
range of tumor cells has been shown to be defective in one or more of
the elements that comprise these genome damage response pathways (see Ref. 1), indicating that such responses play a key role in limiting
tumor cell formation.
A central figure in many damage response pathways is the tumor
suppressor protein p53. p53 is a transcription factor that, when
active, serves to up-regulate the cellular abundance of a cadre of
molecules important in genotoxic response. Such p53-inducible proteins
include p21WAF-1/CIP-1, bax, mdm2, gadd45, and
KILLER/DR5, which perform a variety of functions in response to DNA
damage such as halting cell growth and/or propelling cells into
apoptosis (2) Thus, p53 performs a pivotal role in choreographing
appropriate cellular response to genome damaging events.
Other proteins responsible for an appropriate and timely response to
IR-induced genome damage are members of a protein kinase family which
share homology to the lipid kinase phosphotidylinositol-3 kinase (3,
4). ATM, the protein mutated in the human genetic disorder
ataxia-telangiectasia (A-T), is an important member of this kinase
family. Cells from A-T patients are radiosensitive and have been shown
to be deficient in a number of signaling events that normally occur
following DSB formation (see Ref. 5). For example, A-T cells display
faulty cell cycle checkpoint function in response to IR exposure
(6-9). Recent work has shown that ATM directly phosphorylates p53 in
response to -irradiation (10, 11). The lack of ATM-mediated
irradiation-induced phosphorylation of p53 is likely to be directly
responsible for the blunted up-regulation of
p21WAF-1/CIP-1 in A-T cells resulting in their
G1/S cell cycle checkpoint defect (12-14). In addition,
A-T cells are also defective in several apparent p53-independent
responses such as the activation of c-Abl (15) and the phosphorylation
of the p34 subunit of replication protein A (16).
Another member of the ATM family of protein kinases which plays an
important role in genome damage response is the catalytic subunit of
DNA-dependent protein kinase (DNA-PKcs). Deficiencies in
DNA-PKcs activity are responsible for the lack of appropriate response
to DSBs observed in the radiosensitive mammalian xrs-6 cell line (17)
and scid (severe combined immunodeficiency) mouse strain
(18, 19). The mutant phenotypes displayed by these lines and mice
indicate that loss of DNA-PKcs catalytic activity results in defective
DSB rejoining and the inability to facilitate V(D)J recombination. The
functional contribution of DNA-PKcs-dependent phosphorylation to DSB responses is currently unclear; however, recent
studies have shown that DNA-PK, unlike ATM, is not involved in the
activation of irradiation-induced cell cycle checkpoints (20, 21).
The DNA-PK holoenzyme consists of three subunits: a ~450-kDa
catalytic subunit (DNA-PKcs) and a heterodimeric complex composed of
the proteins Ku70 (70 kDa) and Ku80 (86 kDa). The Ku proteins were
originally identified as autoantigens in patients with autoimmune disorders (22) and were found to bind tightly to linear duplex DNA
(23). Following the generation of DSBs by either exogenous forces
(e.g. -irradiation) or intrinsic mechanisms
(e.g., during V(D)J recombination) the Ku70-Ku80 complex
binds to free DNA ends and subsequently recruits and activates DNA-PKcs
at the site of DSBs (24).
In this manuscript we report that cellular levels of Ku70, but not
Ku80, increase multifold within the nucleus of irradiated cells.
Up-regulation of Ku70 following IR requires both functional p53 and
ATM. Furthermore, we report that up-regulation of Ku70 is not required
for appropriate activation of DNA-PK activity following genome damage.
These results indicate that, in addition to its characterized function
in activating DNA-PK, Ku70 plays yet another role(s) in DNA damage response.
 |
EXPERIMENTAL PROCEDURES |
Cell Lines and Culture Conditions--
Normal diploid human lung
fibroblast line MRC-5 was obtained from the American Type Tissue
Collection. Cells were cultured in Eagle's minimum essential medium
supplemented with 10% fetal calf serum. Human lung carcinoma line
H1299 and its derivative temperature-sensitive line H1299-Val-138 (25)
were cultured in Dulbecco's modified Eagle's medium supplemented with
10% fetal calf serum at 37 °C as were fibroblasts cultured from
c-abl / mice. Where indicated, H1299-Val-138 cells were
shifted to an incubator maintained at 32 °C for 6 h prior to
irradiation. Normal (GM0536A and B-310) and A-T lymphoblast (GM01525E
and IARC12/AT3) lines were grown in RPMI 1640 containing 20%
heat-inactivated fetal calf serum. GM0536A and GM01525E lines were
obtained from NIGMS Human Genetic Mutant Cell Repository (Camden, NJ).
All cell lines were grown in a humidified 5% CO2
atmosphere at 37 °C. Where indicated, cells were exposed to 10 Gy of
IR from a 137Cs source (Gammacell 1000, Atomic Energy of
Canada Ltd.; dose rate, 318 rad/min). Following irradiation, cells were
returned to the incubator and harvested at the indicated time points.
Antibodies--
The Ku70 mouse monoclonal antibody Ab-5, Ku80
monoclonal antibody Ab-2, and DNA-PKcs monoclonal antibody Ab-2 were
purchased from Lab Vision Corporation (Fremont, CA). The anti-p53
antibody DO-1 was obtained from Santa Cruz Biotechnology (Santa Cruz,
CA). The anti- -tubulin monoclonal antibody DM1A was a generous gift from Dr. D. W. Cleveland (Ludwig Institute for Cancer Research, La Jolla, CA).
Electrophoresis and Immunoblotting--
At the indicated time
points, cells were harvested with trypsin, washed three times with cold
(4 °C) PBS, and lysed by the addition of SDS-solubilization buffer
(125 mM Tris-HCl, pH 7.5, 5 mM EDTA, and 1%
SDS). Lysates were then boiled for 5 min, sonicated briefly,
centrifuged (5 min/14,000 rpm), and the supernatants were removed and
stored at 80 °C. Protein concentrations were determined using the
BCA protein assay (Pierce). Prior to electrophoresis, appropriate
volumes of cell lysates were diluted in 3 × SDS-sample buffer
(150 mM Tris-HCl, pH 6.8, 10% -mercaptoethanol, 20%
glycerol, 3% SDS, 0.01% bromphenol blue, 0.01% pyronin-Y) and boiled
for 2 min. SDS-polyacrylamide gel electrophoresis, electrotransfer of
the gels to nitrocellulose sheets, and antibody labeling were conducted
as outlined (26). Immunoreactive bands were visualized using
Supersignal CR-HRP (Pierce) chemiluminescent substrate and recorded on
Kodak XAR film. Quantitation of immunoblot signals was performed using
an Agfa SnapScan flatbed scanner and the NIH Image (version 1.62)
software package using the integrated density function. In all cases,
protein loadings and antibody dilutions were adjusted to assure that
immunoblotting was conducted at subsaturating conditions.
In Vitro Kinase Assays--
Kinase reactions were performed
using an adaptation of the DNA-PKcs immunoprecipitation-based protocol
of Kurimasa et al. (27). Briefly, cells were irradiated with
10 Gy of -radiation and collected at indicated time points. The
cells were subsequently washed with ice-cold PBS and lysed in 1 × lysis buffer (20 mM Tris-HCl, pH 7.5, 150 mM
NaCl, 5 mM EDTA, 0.5% Nonidet P-40, 1 mM NAF,
1 mM dithiothreitol, 1 mM sodium vanadate, and
protease inhibitors (0.5 mM phenylmethylsulfonyl fluoride,
1 µg/ml leupeptin, 1 µg/ml pepstatin-A)). After adjusting the
lysate concentration for equal protein content, DNA-PKcs antibody was
added to the lysate at a concentration of 5.0 µg/mg lysate and
incubated for 2 h on ice. After this step, 15 µl of a 50%
slurry (in PBS) of protein A/G-Sepharose beads (Amersham Pharmacia
Biotech) were added, and the incubation was continued for another
1 h on an end-over-end rotator at 4 °C. The immune complexes
were washed three times with lysis buffer containing 500 mM
NaCl and twice with kinase buffer (25 mM HEPES, pH 7.5, 500 mM KCl, 0.5 mM EDTA, 5 mM
dithiothreitol, 2.5 mM phenylmethylsulfonyl fluoride). The beads were then suspended in a minimal volume of kinase buffer and used
in kinase reactions.
Kinase reactions were carried out in a final reaction volume of 35 µl. To the slurry of beads containing immunoprecipitated DNA-PKcs, 1 µg of bacterially synthesized, purified recombinant GST-p53 fusion
protein, 5 µM cold ATP, 30 µCi of
[32P- ]ATP (7,000 Ci/mmol, ICN) and 500 ng of sonicated
salmon sperm DNA were added. This reaction was incubated at room
temperature for 30 min and terminated by adding an equal volume of
3 × SDS-sample buffer followed by immersion in a boiling water
bath. The reaction products were resolved on 8% acrylamide gels and
electrically transferred onto Immobilon-P sheets (Millipore) using a
Bio-Rad semidry transfer apparatus. Quantitation was done using a
Bio-Rad laser densitometer (GS-710 calibrated imaging densitometer).
Subcellular Fractionation--
Subcellular fractionation was
carried out as described previously (26). Approximately 2 × 107 irradiated (10 Gy) and nonirradiated MRC-5 fibroblasts
were harvested by scraping and rinsed twice in-cold PBS. The cells were
then swollen in ice-cold hypotonic lysis buffer (20 mM
HEPES, pH 7.1, 5 mM KCl, 1 mM
MgCl2, 10 mM N-ethylmaleimide, and
protease inhibitors (0.5 mM phenylmethylsulfonyl fluoride,
5.0 µg/ml pepstain-A, 2.0 µg/ml chymostain, 5.0 µg/ml leupeptin,
5.0 µg/ml aprotinin, 5.0 µg/ml antipain)) for 10 min on ice. The
cells were then lysed by 20 strokes in a Dounce homogenizer with a
tight pestle and the nuclei cleared by centrifugation (400 × g, 10 min). Following this step, the supernatant (cytosolic
fraction) was transferred to a Centricon microconcentrator (Amicon),
concentrated approximately 5-fold, and subsequently stored at
80 °C. The nuclei were washed three times in lysis buffer and
stored at 80 °C prior to analysis.
Immunofluorescence Microscopy--
Indirect immunofluorescence
microscopy was conducted as outlined previously (26). MRC-5 fibroblasts
were cultured on sterilized glass coverslips to ~75% confluence
prior to irradiation. Postirradiation the cells were fixed by immersion
in PBS containing 3.0% formaldehyde for 30 min at room temperature,
after which the cells were permeabilized by immersion in PBS containing
0.1% Triton X-100. Following this step the coverslips were rinsed in
PBS and blocked by immersion in PBS containing 5% bovine serum
albumin. Immunofluorescent staining was done using anti-Ku70 followed
by fluorescein isothiocyanate-labeled anti-mouse secondary antibody
(Kirkegaard and Perry Laboratories, Gaithersburg, MD). Cells were
counterstained with Hoescht 33258 (0.1 µg/ml final concentration) to
reveal DNA. Images were captured on 35-mm film (Kodak T-Max 400) using
a Nikon microscope equipped with epifluorescence optics.
 |
RESULTS |
Cellular Levels of Ku70 Rise Following IR Exposure--
In our
efforts to define signal transduction pathways that are activated
following genotoxic events we have investigated the fluctuation of the
Ku70 and Ku80 autoantigens following IR exposure. The Ku70-Ku80 complex
is responsible for the activation of DNA-PKcs in part because of its
intrinsic property of binding to free DNA ends with high affinity.
Hence, it is conceivable that the cellular levels of Ku70 and/or Ku80
could be influenced positively in response to the introduction of DSBs
into the genome. An initial report on this subject (28) indicated that
in normal peripheral blood lymphocytes and a leukemia tumor cell line
exposure to -irradiation resulted in an apparent 3-4-fold rise in Ku70.
To confirm that Ku70 levels are altered in response to IR exposure we
subjected normal human diploid lung fibroblasts (MRC-5 cells) to
analysis following -irradiation. 2 h following 10 Gy of IR we
measured an approximate 3-fold rise in Ku70 (mean = 2.7 ± 0.5 S.D., n = 5) over the levels present in
nonirradiated cells (Fig. 1a).
This quantitative increase in Ku70 was observed 30 min after
irradiation and persisted during the analyzed 2-h time frame. We have
examined MRC-5 cells 6 h postirradiation and observed no further
significant Ku70 accumulation than what was noted 2 h after IR
exposure (data not shown). We noted a slight increase in cellular
levels of the Ku80 protein after IR exposure (Fig. 1b);
however, this increase was significantly blunt compared with the
observed rise in Ku70 during the same time period. As expected, we
noted a 5-7-fold rise in p53 following IR exposure during this period
(Fig. 1c). An immunoblot run in parallel and probed with anti-tubulin confirmed equivalent protein loadings (Fig.
1d).

View larger version (59K):
[in this window]
[in a new window]
|
Fig. 1.
Ionizing radiation exposure results in
up-regulation of cellular Ku70 levels. Logarithically growing
cultures of MRC-5 normal human lung fibroblasts were subjected to 10 Gy
of IR, and extracts were prepared at the indicated times. Extracts were
subjected to immunoblot analysis with anti-Ku70 (a),
anti-Ku80 (b), anti-p53 (c), or anti- -tubulin
(d). Relative immunoblot signal intensities for Ku70, Ku80,
and p53 immunoblots are indicated.
|
|
p53 and ATM Are Required for Postirradiation Up-regulation of Ku70
Levels--
p53 is responsible for the up-regulation of a number of
proteins in response to genotoxic events (2). To determine if Ku70 up-regulation observed in normal human fibroblasts is a
p53-dependent event, we measured Ku70 accumulation in
irradiated H1299 cells, a p53-null human lung carcinoma cell line (29).
Irradiation of these cells with 10 Gy of IR resulted in no significant
increase in cellular levels of Ku70 at 2 h (1.1-fold rise ± 0.15, n = 7) (Fig.
2a).

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 2.
p53 is required for the postirradiation rise
in Ku70 levels. a, cultures of the p53-null human lung
carcinoma cell line H1299 were subjected to 10 Gy of IR, and extracts
were prepared at the indicated times. Extracts were subjected to
immunoblot analysis with anti-Ku70 (upper panel) or anti
-tubulin (lower panel). b, cultures of
H1299-Val-138 (V138) cells which express a
temperature-sensitive form of human p53 were cultured at the permissive
temperature (32 °C) for 6 h and then irradiated (10 Gy).
Extracts were formed and analyzed as in a. c, H1299-Val-138
cells cultured at the nonpermissive temperature (37 °C) were
irradiated (10 Gy), and extracts were formed and analyzed as indicated
in a. The relative Ku70 immunoblot signal intensity is
indicated.
|
|
To confirm that loss of functional p53 in H1299 cells was the
underlying cause of loss of irradiation-dependent Ku70
increase we employed a derivative cell line that expresses a
conditionally functional form of p53. This cell line, termed
H1299-Val-138, is engineered to express ectopically a human p53
molecule that contains an alanine to valine mutation at codon 138 (25).
This change renders the molecule temperature-sensitive, similar to an
equivalent alanine to valine mutation at codon 135 in murine p53 (30).
When H1299-Val-138 cells were cultured for 6 h at the permissive
temperature (32 °C) and then irradiated with 10 Gy of IR these cells
showed, 2 h after irradiation, an approximate 2-fold up-regulation
of cellular Ku70 levels (1.9 ± 0.5, n = 8) (Fig.
2b). Conversely, when irradiated H1299-Val-138 cells were maintained at the nonpermissive temperature (37 °C) there was no
observed increase in Ku70 levels at the same time point (1.0 ± 0.4 h, n = 8) (Fig. 2c). Taken
together, these findings validate that the postirradiation rise in Ku70
is dependent on p53.
ATM has been shown to phosphorylate p53 in response to IR exposure (10,
11) and is required for the p53-dependent rise in several
proteins following DSB formation (see Refs. 5 and 31). To determine if
p53-dependent up-regulation of Ku70 levels requires ATM
function we subjected normal human and A-T patient lymphoblasts to 10 Gy of -irradiation. (Lymphoblasts are Epstein-Barr virus-immortalized peripheral blood lymphocytes and have been shown to
possess intact p53-dependent responses (7, 13).) Consistent
with the observations of Kumaravel et al. (28) we observed
an approximate 2-fold increase in Ku70 in normal lymphoblasts 2 h
after IR exposure (2.1 ± 0.6, n = 5) (Fig.
3a). However, we observed no
postirradiation increase in Ku70 in either the A-T lymphoblast lines
IARC12/AT3 (1.0 ± 0.26, n = 5) or GM01525E
(1.0 ± 0.39, n = 8) (Fig. 3, b and
c) 2 h after IR exposure. Further, two additional A-T
lymphoblast lines displayed parallel results (data not shown). These
observations indicate that in addition to p53, ATM is required for the
up-regulation of Ku70 after irradiation.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 3.
A-T cells do not display an
irradiation-induced rise in Ku70 levels. a, normal
lymphoblast line B-310 cells were exposed to 10 Gy of IR and subjected
to immunoblot analysis with anti-Ku70 (upper panel) and
anti- -tubulin (lower panel) at the indicated time points.
b, A-T lymphoblast line IARC12/AT3 cells were exposed to 10 Gy of IR and analyzed as in a. c, A-T lymphoblast line
GM01525E cells were exposed to 10 Gy of IR and analyzed as in
a. The relative Ku70 immunoblot signal intensity is
indicated.
|
|
DNA-PK Activation Occurs Normally in the Absence of IR-induced Ku70
Accumulation--
Previous work has shown that Ku70 and Ku80 play an
essential role in activating DNA-PKcs (24). Hence, we examined if the observed rapid up-regulation of Ku70 levels was required for timely activation of DNA-PKcs after IR exposure. To address this issue we
irradiated H1299-Val-138 cells cultured at both the permissive and
nonpermissive temperature with 10 Gy of IR and subsequently measured
DNA-PKcs activity by employing an in vitro kinase assay using recombinant GST-p53 as a substrate (p53 has been shown to be an
in vitro substrate for DNA-PKcs catalytic activity (32)). At
the permissive temperature (active p53) we observed a 4-fold rise in
DNA-PK-associated p53 phosphorylation after -irradiation (Fig.
4a). Equivalent results were
observed in extracts of irradiated H1299-Val-138 cells cultured at the
nonpermissive temperature (Fig. 4b). Immunoblots with
anti-DNA-PKcs confirmed the presence of equivalent amounts of
immunoprecipitated DNA-PKcs in each of the kinase assays. Further, we
observed normal activation of DNA-PK activity in irradiated A-T
lymphoblastoid cells (data not shown). These findings clearly indicate
that the irradiation-induced rise in Ku70 is not required for DNA-PK
activation.

View larger version (42K):
[in this window]
[in a new window]
|
Fig. 4.
Lack of Ku70 up-regulation has no effect on
the postirradiation activation of DNA-PKcs. a,
H1299-Val-138 cells were cultured at the nonpermissive temperature
(32 °C) for 6 h prior to exposure to -irradiation (10 Gy).
At the indicated time points after irradiation, extracts from the cells
were formed, DNA-PKcs was immunoprecipitated, and associated kinase
activity was determined by in vitro phosphorylation of
purified recombinant human p53-GST fusion protein (upper
panel) as outlined under "Experimental Procedures." To ensure
that equivalent amounts of DNA-PKcs were subjected to kinase assays,
the immunoprecipitated material was subjected to immunoblot analysis
with DNA-PKcs antibody (lower panel). b,
H1299-Val-138 cells were cultured at the nonpermissive temperature
(37 °C), exposed to -irradiation (10 Gy), and analyzed as in
a. The relative signal intensity of the radiolabeled p53-GST
is shown.
|
|
IR Exposure Results in Increased Levels of Ku70 in the
Nucleus--
We examined the localization of Ku70 in irradiated cells.
MRC-5 cells were exposed to -irradiation (10 Gy), and 2 h and
18 h postirradiation these cells and nonirradiated controls were subjected to immunofluorescence microscopy. Contrary to the findings of
Kumaravel et al. (28) who observed Ku70 accumulation within the cytoplasm 18 h postirradiation, we found Ku70 localized
exclusively within the nucleus in both nonirradiated cells and
irradiated cells (Fig. 5a).
Negligible cytoplasmic staining was observed.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 5.
Ku70 accumulates within the nucleus of
irradiated human fibroblasts. a, MRC-5 fibroblasts were
seeded on presterilized coverslips and either unexposed (No
IR) or exposed to 10 Gy of IR and processed for immunofluorescence
microscopy 2 h (+IR-2 h) or 18 h (+IR-18
h) postirradiation. The cells were labeled with anti-Ku70 and
counterstained with Hoescht 33258 to stain DNA fluorescently. Note the
colocalization of Ku70 with nuclei in all cells and the general absence
of Ku70 staining in the cytoplasm. b, approximately 2 × 107 irradiated MRC-5 cells (10 Gy, 2 h
postirradiation) and an equal number of nonirradiated cells were
subjected to subcellular fractionation. 10% of the isolated nuclear
(lanes 1 and 3) and cytoplasmic (lanes
2 and 4) fractions from nonirradiated (lanes
1 and 2) and irradiated cells (lanes 3 and
4) were subjected to immunoblot analysis with anti-Ku70
(upper panel). Additionally, 2.5% of these fractions were
subjected to immunoblot analysis with anti-tubulin (lower
panel) to confirm complete cell lysis.
|
|
To confirm these findings independently, we subjected irradiated and
nonirradiated MRC-5 cells to subcellular fractionation (Fig.
5b). Analysis of nuclear fractions by immunoblotting showed a significant elevation of Ku70 within the nuclear fraction of irradiated cells compared with nonirradiated controls, consistent with
the immunofluorescence studies. Ku70 was not detected in the
cytoplasmic fractions obtained from either irradiated or nonirradiated fibroblasts. -Tubulin (a cytoplasmic protein) was detected
predominantly in the cytoplasmic fractions, indicating that lysis was
virtually complete. We are unsure why our results differ from the
observations of Kumaravel et al. (28); however, others have
noted a difference in Ku70 localization in lymphoid and fibroblast type
cells (33). Nevertheless, our data indicate that this protein
accumulates exclusively within the nucleus in irradiated fibroblasts.
 |
DISCUSSION |
The evidence presented in this study indicates that ionizing
radiation results in increased cellular levels of Ku70, a finding that
is in agreement with a previously published report (28). Using lymphoid
cells, Kumaravel and co-workers noted a 3-4-fold increase in Ku70
2 h postirradiation (earlier time points were not assayed), and
this elevated level persisted for 72 h. We have extended this work
by demonstrating that in both human fibroblasts and lymphoblasts, Ku70
undergoes a similar (2-3-fold) rise rapidly (within 30 min) after
irradiation and that this phenomenon requires both functional ATM and
p53. Additionally, we have found that Ku70 levels rise in irradiated
normal and c-abl / mouse
fibroblasts,2 indicating that
the up-regulation of Ku70 is independent of c-Abl activity and
IR-induced Ku70 up-regulation is a feature common to many, if not all,
normal cell types.
Our observation that the up-regulation of Ku70 requires both functional
ATM and p53 leads us to propose the following signal cascade: DSB > ATM > p53 > Ku70. The involvement of p53 in
postirradiation Ku70 up-regulation suggests that this phenomenon is
caused by increased p53-mediated transcription of the Ku70 gene.
However, preliminary evidence failed to detect a rise in Ku70 mRNA
2 h after -irradiation as judged by Northern blot analysis
(data not shown). Thus, at this time, we are unsure of the nature of the molecular mechanism that gives rise to the observed increase in
Ku70 levels.
Although we documented the multifold up-regulation of Ku70 after
irradiation, we noted no similar rise in its heterodimeric binding
partner Ku80, a finding that is in agreement with other reports (34).
This observation suggests that the postirradiation rise in Ku70 does
not result in higher cellular concentrations of the Ku70-Ku80
heterodimer. Interestingly, a splice variant of the Ku80 protein termed
KARP-1 (35) has been also shown to be up-regulated following IR
exposure in an ATM/p53-dependent manner (34). Like the
Ku70-Ku80 complex, several lines of evidence indicate that KARP-1 is
involved in modulating DNA-PK activity (35). Thus, it is tempting to
speculate that KARP-1 and Ku70 may form a complex after DNA damage
because such events lead to increased abundance of both molecules.
Diminution of DNA-PK activity has been shown to be responsible for the
scid defect in mice (18, 19). One of the phenotypic hallmarks of scid cells is extreme radiosensitivity,
indicating the requirement for DNA-PK activity in responding
appropriately to genome damage. Similarly, cells harboring mutated Ku80
or Ku70 alleles are also radiosensitive (36-39), reinforcing the
concept that Ku function is required for DNA-PKcs activation.
Observations made on recently developed Ku70 / or Ku80 / mice
have begun to shed light on possibility that the Ku proteins perform
functions that are independent of their role in DNA-PKcs activation.
Ku80- (37, 38) and Ku70-deficient mice (39), in addition to displaying
radiosensitivity, are of significantly reduced size compared with wild
type or heterozygous littermates. On the other hand, DNA-PKcs-deficient
mice do not display such growth retardation (40), indicating that Ku
proteins play a role in development which is independent of DNA-PKcs.
Furthermore, scid mice and DNA-PKcs-deficient mice display
blocked V(D)J coding end joining but show overall normal signal joint
formation (40-42), whereas Ku80 / mice display both defective
coding and signal joint formation (37, 38). Paradoxically, whereas
DNA-PKcs / and Ku80 / mice display both abnormal T- and
B-lymphocyte development, Ku70 / mice showed abnormal B-lymphocyte
but normal T-lymphocyte development and maturation (39), indicating
that TCR and V(D)J recombination requires both DNA-PKcs and Ku80 but
not Ku70. Taken together, these observations argue that both Ku80 and
Ku70 perform functions independent of the activation of DNA-PKcs and
that Ku70 and Ku80 may possess some separable functions.
Several lines of evidence indicate that the Ku proteins play an
essential role in DNA repair. For example, Ku80- and Ku70-deficient mice show severe impairment in their ability to repair DSBs (38, 39).
Additionally, Saccharomyces cerevisiae mutants that do not
express either the yeast homologs of Ku80 or Ku70 show diminished capacity for the repair of DSBs (43, 44). (It bears noting that
although S. cerevisiae does express a number of ATM-related kinases (i.e. Mec1p, Tel1p, Tor1p, and Tor2p), a DNA-PKcs
homolog has not been identified in this organism to date.) In addition to the aforementioned property of binding to free DNA ends, in vitro studies have shown that the Ku heterodimer can translocate internally on DNA fragments (45), transfer between DNA fragments possessing cohesive ends (46), and join DNA fragments (47). Further,
Ku70-Ku80 facilitates ligation of DNA molecules possessing small (<4
base pairs), blunt, or noncohesive termini by eukaryotic ligases (48),
and Ku has been shown to protect free DNA ends from nuclease digestion
(49). Such observations have fueled a current view that Ku proteins
perform an important role(s) in nonhomologous end joining, the primary
mode of DSB repair in mammalian cells (50).
Although not grossly deficient in DNA repair, several studies indicate
that A-T cells display faulty DSB repair (51-53). Given our findings
that Ku70 levels are not up-regulated in irradiated A-T cells, we
propose that the lower relative abundance of Ku70 in A-T cells
following irradiation may contribute to the observed deficiencies in
DSB repair in these cells. This potential role for the IR-induced
increase in cellular levels of Ku70 is in agreement with our finding
that this protein accumulates within the nucleus of irradiated cells.
Hence, by up-regulating nuclear Ku70 levels following irradiation the
cell may have evolved a mechanism that ensures a sufficient supply of
Ku70 to fully facilitate DSB repair following genome damage.
It is becoming apparent that -irradiation results in global changes
in transcriptional activity via both p53-dependent and -independent mechanisms (54). Ku has been shown to be a
sequence-specific DNA-binding protein (55), and several genes have been
identified which contain regions that bind Ku (56-59). Although little
direct evidence indicates that the binding of Ku to these or any other genes has a direct effect on modulating transcriptional activity, these
findings do make this a possibility worthy of consideration. Alternatively, Ku70 has been shown to interact with the nuclear tyrosine kinase c-Abl (60) and thus may potentially influence the
phosphorylation of the carboxyl-terminal domain of RNA polymerase II by
c-Abl. Phosphorylation of the RNA polymerase II COOH-terminal domain
has recently been shown to have a strong effect on RNA polymerase
II-mediated transcription (61).
In conclusion, we have found that -irradiation results in an
up-regulation of Ku70 leading to enhanced levels of Ku70 within the
nucleus. We have also provided evidence that the up-regulation of Ku70
utilizes a mechanism that is dependent on both ATM and p53 but that
Ku70 up-regulation is not a required event for DNA-PK activation. These
findings support the notion that the damage-induced up-regulation of
Ku70 provides the cell with a means of assuring either proper DNA
repair or appropriate response to DNA damage.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Bryan Gebhardt (Department of
Opthamology, LSUMC) for generously allowing us access to the
137Cs irradiator and Dr. S. Drury for critically reading
the manuscript.
 |
FOOTNOTES |
*
This work was supported by Research Project Grant GMC-98564
from the American Cancer Society and by the Cancer Association of
Greater New Orleans (to K. D. B.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Dept. of
Biochemistry and Molecular Biology, LSU Medical Center, 1901 Perdido St., MEB Rm. 7101, New Orleans, LA 70112. Tel.: 504-568-2090; Fax:
504-568-3370; E-mail: kbrown1@lsumc.edu.

Present address: Molecular Oncology Program, H. Lee Moffit
Cancer Center, University of South Florida, Tampa, FL 33612.
2
S. Shangary and R. Baskaran, unpublished results.
 |
ABBREVIATIONS |
The abbreviations used are:
IR, ionizing
radiation;
DSB, double strand break;
A-T, ataxia telangiectasia;
ATM, ataxia telangiectasia-mutated;
DNA-PK, DNA-dependent protein kinase;
DNA-PKcs, catalytic subunit of DNA-dependent protein kinase;
scid, severe combined immunodeficiency;
Gy, gray(s);
PBS, phosphate-buffered saline;
GST, glutathione
S-transferase.
 |
REFERENCES |
| 1.
|
Smith, M. L.,
and Fornace, A. J.
(1995)
Curr. Opin. Oncol.
7,
69-75[Medline]
[Order article via Infotrieve]
|
| 2.
|
el-Deiry, W. S.
(1998)
Semin. Cancer Biol.
8,
345-357[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Zakian, V. A.
(1995)
Cell
82,
685-687[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Lavin, M. F.,
Khanna, K. K.,
Beamish, H.,
Spring, K.,
Watters, D.,
and Shiloh, Y.
(1995)
Trends Biol. Sci.
20,
382-383
|
| 5.
|
Brown, K. D.,
Barlow, C.,
and Wynshaw-Boris, A.
(1999)
Am. J. Hum. Genet.
64,
46-50[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Painter, R. B.
(1981)
Mutat. Res.
84,
183-190[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Beamish, H.,
Williams, R.,
Chen, P.,
and Lavin, M. F.
(1996)
J. Biol. Chem.
271,
20486-20493[Abstract/Free Full Text]
|
| 8.
|
Little, J. B.,
and Nagasawa, H.
(1985)
Radiat. Res.
101,
81-93[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Rudolph, N. S.,
and Latt, S. A.
(1989)
Mutat. Res.
211,
31-41[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Banin, S.,
Moyal, L.,
Shieh, S.,
Taya, Y.,
Anderson, C. W.,
Chessa, L.,
Smorodinsky, N. I.,
Prives, C.,
Reiss, Y.,
Shiloh, Y.,
and Ziv, Y.
(1998)
Science
281,
1674-1677[Abstract/Free Full Text]
|
| 11.
|
Canman, C. E.,
Lim, D. S.,
Cimprich, K. A.,
Taya, Y.,
Tamai, K.,
Sakaguchi, K.,
Appella, E.,
Kastan, M. B.,
and Siliciano, J. D.
(1998)
Science
281,
1677-1679[Abstract/Free Full Text]
|
| 12.
|
Dulic, V.,
Kaufmann, W. K.,
Wilson, S. J.,
Tlsty, T. D.,
Lees, E.,
Harper, J. W.,
Elledge, S. J.,
and Reed, S. I.
(1994)
Cell
76,
1013-1023[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Canman, C. E.,
Wolff, A. C.,
Chen, C.-Y.,
Fornace, A. J.,
and Kastan, M. B.
(1994)
Cancer Res.
54,
5054-5058[Abstract/Free Full Text]
|
| 14.
|
Barlow, C.,
Brown, K. D.,
Deng, C.-X.,
Tagle, D. A.,
and Wynshaw-Boris, A.
(1997)
Nat. Genet.
17,
453-456[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Baskaran, R.,
Wood, L. D.,
Whitaker, L. L.,
Canman, C. E.,
Morgan, S. E.,
Xu, Y.,
Barlow, C.,
Baltimore, D.,
Wynshaw-Boris, A.,
Kastan, M. B.,
and Wang, J. Y. J.
(1997)
Nature
387,
516-519[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Liu, V. F.,
and Weaver, D. T.
(1993)
Mol. Cell. Biol.
13,
7222-7231[Abstract/Free Full Text]
|
| 17.
|
Finnie, N. J.,
Gottlieb, T. M.,
Blunt, T.,
Jeggo, P. A.,
and Jackson, S. P.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
320-324[Abstract/Free Full Text]
|
| 18.
|
Blunt, T.,
Finnie, N. J.,
Taccioli, G. E.,
Smith, G. C. M.,
Demengeot, J.,
Gottlieb, T. M.,
Mizuta, R.,
Varghese, A. J.,
Alt, F. W.,
Jeggo, P. A.,
and Jackson, S. P.
(1995)
Cell
80,
813-823[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Kirchgessner, C. U.,
Patil, C. K.,
Evans, J. W.,
Cuomo, C. A.,
Fried, L. M.,
Carter, T.,
Oettinger, M. A.,
and Brown, J. M.
(1995)
Science
267,
1178-1183[Abstract/Free Full Text]
|
| 20.
|
Burma, S.,
Kurimasa, A.,
Xie, G.,
Taya, Y.,
Araki, R.,
Abe, M.,
Crissman, H. A.,
Ouyang, H.,
Li, G. C.,
and Chen, D. J.
(1999)
J. Biol. Chem.
274,
17139-17143[Abstract/Free Full Text]
|
| 21.
|
Jimenez, G. S.,
Bryntesson, F.,
Torres-Arzayus, M. I.,
Priestley, A.,
Beeche, M.,
Saito, S.,
Sakaguchi, K.,
Appella, E.,
Jeggo, P. A.,
Taccioli, G.,
Wahl, G. M.,
and Hubank, M.
(1999)
Nature
400,
81-83[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Reeves, W. H.
(1992)
Rheum. Dis. Clin. North. Am.
18,
391-414[Medline]
[Order article via Infotrieve]
|
| 23.
|
Mimori, T.,
Hardin, J. A.,
and Steitz, J. A.
(1986)
J. Biol. Chem.
261,
2274-2278[Abstract/Free Full Text]
|
| 24.
|
Gottlieb, T. M.,
and Jackson, S. P.
(1993)
Cell
72,
131-142[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Pochampally, R.,
Fodera, B.,
Chen, L.,
Wenge, L.,
and Chen, J.
(1999)
J. Biol. Chem.
274,
15271-15277[Abstract/Free Full Text]
|
| 26.
|
Brown, K. D.,
Ziv, Y.,
Sadandanan, S. N.,
Chessa, L.,
Collins, F. S.,
Shiloh, Y.,
and Tagle, D. A.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
1840-1845[Abstract/Free Full Text]
|
| 27.
|
Kurimasa, A.,
Kumano, S.,
Boubnov, N. V.,
Story, M. D.,
Tung, C. S.,
Peterson, S. R.,
and Chen, D. J.
(1999)
Mol. Cell. Biol.
19,
3877-3884[Abstract/Free Full Text]
|
| 28.
|
Kumaravel, T. S.,
Bharthy, K.,
Kudoh, S.,
Tanaka, K.,
and Kamada, N.
(1998)
Int. J. Radiat. Biol.
74,
481-489[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Mitsudomi, T.,
Steinberg, S. M.,
Nau, M. M.,
Carbone, D.,
D'Amico, D.,
Bodner, S.,
Oie, H. K.,
Linnoila, R. I.,
Mulshine, J. L.,
Minna, J. D.,
and Gazdar, A. F.
(1992)
Oncogene
7,
171-180[Medline]
[Order article via Infotrieve]
|
| 30.
|
Michalovitz, D.,
Halevy, O.,
and Oren, M.
(1990)
Cell
62,
671-680[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Rotman, G.,
and Shiloh, Y.
(1998)
Hum. Mol. Genet.
7,
1555-1563[Abstract/Free Full Text]
|
| 32.
|
Lees-Miller, S. P.,
Sakaguchi, K.,
Ullrich, S. J.,
Appella, E.,
and Anderson, C. W.
(1992)
Mol. Cell. Biol.
12,
5041-5049[Abstract/Free Full Text]
|
| 33.
|
Grandvaux, N.,
Grizot, S.,
Vignais, P. V.,
and Dagher, M. C.
(1999)
J. Cell Sci.
112,
503-513[Abstract]
|
| 34.
|
Myung, K.,
Braastad, C.,
He, D. M.,
and Hendrickson, E. A.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
7664-7669[Abstract/Free Full Text]
|
| 35.
|
Myung, K.,
He, D. M.,
Lee, S. E,
and Hendrickson, E. A.
(1997)
EMBO J.
18,
3172-3184[CrossRef]
|
| 36.
|
Taccioli, G. E.,
Gottlieb, T. M.,
Blunt, T.,
Priestley, A.,
Demengeot, J.,
Mizuta, R.,
Lehmann, A. R.,
Alt, F. W.,
Jackson, S. P.,
and Jeggo, P. A.
(1994)
Science
265,
1442-1445[Abstract/Free Full Text]
|
| 37.
|
Nussenzweig, A.,
Chen, C.,
da Costa Soares, V.,
Sanchez, M.,
Sokol, K.,
Nussenzweig, M. C.,
and Li, G. C.
(1996)
Nature
382,
551-555[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Zhu, C. M.,
Bogue, M. A.,
Lim, D. S.,
Hasty, P.,
and Roth, D. B.
(1996)
Cell
86,
379-389[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Ouyang, B. H.,
Nussenzweig, A.,
Kurimasa, A.,
da Costa Soares, V.,
Li, X.,
Cordon-Cardo, C.,
Li, W.,
Cheong, N.,
Nussenzweig, M.,
Iliakis, G.,
Chen, D. J.,
and Li, G. C.
(1997)
J. Exp. Med.
186,
921-929[Abstract/Free Full Text]
|
| 40.
|
Taccioli, G. E.,
Amatucci, A. G.,
Beamish, H. J.,
Gell, D.,
Xiang, X. H.,
Torres Arzayus, M. I.,
Priestley, A.,
Jackson, S. P.,
Rothstein, A. M.,
Jeggo, P. A.,
and Herrera, V. L. M.
(1998)
Immunity
9,
355-366[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Lieber, M. R.,
Hesse, J. E.,
Lewis, S.,
Bosma, G. C.,
Rosenberg, N.,
Mizuuchi, K.,
Bosma, M. J.,
and Gellert, M.
(1988)
Cell
55,
7-16[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Gao, Y.,
Chaudhuri, J.,
Zhu, C.,
Davidson, L.,
Weaver, D. T.,
and Alt, F. W.
(1998)
Immunity
9,
367-376[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Milne, G. T.,
Jin, S.,
Shannon, K. B.,
and Weaver, D. T.
(1996)
Mol. Cell. Biol.
16,
4189-4198[Abstract]
|
| 44.
|
Boulton, S. J.,
and Jackson, S. P.
(1996)
EMBO J.
15,
5093-5103[Medline]
[Order article via Infotrieve]
|
| 45.
|
de Vries, E.,
van Driel, W.,
Bergsma, W. G.,
Arnberg, A. C.,
and van der Vliet, P. C.
(1989)
J. Mol. Biol.
208,
65-78[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Bliss, T. M.,
and Lane, D. P.
(1997)
J. Biol. Chem.
272,
5765-5773[Abstract/Free Full Text]
|
| 47.
|
Pang, D.,
Yoo, S.,
Dynan, W. S.,
Jung, M.,
and Dritschillo, A.
(1997)
Cancer Res.
57,
1412-1415[Abstract/Free Full Text]
|
| 48.
|
Ramsden, D. A.,
and Gellert, M. A.
(1998)
EMBO J.
17,
609-614[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Liang, F.,
and Jasin, M.
(1996)
J. Biol. Chem.
271,
14405-14411[Abstract/Free Full Text]
|
| 50.
|
Jeggo, P. A.
(1997)
Mutat. Res.
384,
1-14[Medline]
[Order article via Infotrieve]
|
| 51.
|
Cox, R.,
Debenham, P. G.,
Masson, W. K.,
and Webb, M. B.
(1986)
Mol. Biol. Med.
3,
229-244[Medline]
[Order article via Infotrieve]
|
| 52.
|
Runger, T. M.,
Poot, M.,
and Kraemer, K. H.
(1992)
Mutat. Res.
293,
47-53[CrossRef][Medline]
[Order article via Infotrieve]
|
| 53.
|
Dar, M. E.,
Winters, T. A.,
and Jorgensen, T. J.
(1997)
Mutat. Res.
384,
169-179[Medline]
[Order article via Infotrieve]
|
| 54.
|
Amundson, S. A.,
Bittner, M.,
Chen, Y.,
Trent, J.,
Meltzer, P.,
and Fornace, A. J.
(1999)
Oncogene
18,
3666-3672[CrossRef][Medline]
[Order article via Infotrieve]
|
| 55.
|
Giffin, W.,
Torrance, H.,
Rodda, D. J.,
Prefontaine, G. G.,
Pope, L.,
and Hache, R. J.
(1996)
Nature
380,
265-268[CrossRef][Medline]
[Order article via Infotrieve]
|
| 56.
|
Giffin, W.,
Gong, W.,
Schild-Poulter, C.,
and Hache, R. J.
(1999)
Mol. Cell. Biol.
19,
4065-4078[Abstract/Free Full Text]
|
| 57.
|
Genersch, E.,
Eckerskorn, C.,
Lottspeich, F.,
Herzog, C.,
Kuhn, K.,
and Poschl, E.
(1995)
EMBO J.
14,
791-800[Medline]
[Order article via Infotrieve]
|
| 58.
|
Camara-Clayette, V.,
Thomas, D.,
Rahuel, C.,
Barbey, R.,
Cartron, J. P.,
and Bertrand, O.
(1999)
Nucleic Acids Res.
27,
1656-1663[Abstract/Free Full Text]
|
| 59.
|
Aoki, Y.,
Zhao, G.,
Qiu, D.,
Shi, L.,
and Kao, P. N.
(1998)
Am. J. Physiol.
275,
L1164-L1172[Abstract/Free Full Text]
|
| 60.
|
Kharbanda, S.,
Pandey, P.,
Jin, S.,
Inoue, S.,
Bharti, A.,
Yuan, Z. M.,
Weichselbaum, R.,
Weaver, D.,
and Kufe, D.
(1997)
Nature
386,
732-735[CrossRef][Medline]
[Order article via Infotrieve]
|
| 61.
|
Baskaran, R.,
Escobar, S. R.,
and Wang, J. Y.
(1999)
Cell Growth Differ.
10,
387-396[Abstract/Free Full Text]
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. H. Luo, K. Rosenke, K. Czornak, and E. A. Fortunato
Human Cytomegalovirus Disrupts both Ataxia Telangiectasia Mutated Protein (ATM)- and ATM-Rad3-Related Kinase-Mediated DNA Damage Responses during Lytic Infection
J. Virol.,
February 15, 2007;
81(4):
1934 - 1950.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. V. Singh, A. Herman-Antosiewicz, A. V. Singh, K. L. Lew, S. K. Srivastava, R. Kamath, K. D. Brown, L. Zhang, and R. Baskaran
Sulforaphane-induced G2/M Phase Cell Cycle Arrest Involves Checkpoint Kinase 2-mediated Phosphorylation of Cell Division Cycle 25C
J. Biol. Chem.,
June 11, 2004;
279(24):
25813 - 25822.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Schild-Poulter, A. Shih, N. C. Yarymowich, and R. J. G. Hache
Down-Regulation of Histone H2B by DNA-Dependent Protein Kinase in Response to DNA Damage through Modulation of Octamer Transcription Factor 1
Cancer Res.,
November 1, 2003;
63(21):
7197 - 7205.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kibe, K. Tomita, A. Matsuura, D. Izawa, T. Kodaira, T. Ushimaru, M. Uritani, and M. Ueno
Fission yeast Rhp51 is required for the maintenance of telomere structure in the absence of the Ku heterodimer
Nucleic Acids Res.,
September 1, 2003;
31(17):
5054 - 5063.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Raju, E. Nakata, K. A. Mason, K. K. Ang, and L. Milas
Flavopiridol, a Cyclin-dependent Kinase Inhibitor, Enhances Radiosensitivity of Ovarian Carcinoma Cells
Cancer Res.,
June 15, 2003;
63(12):
3263 - 3267.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Jang, S. Lee, Y. Jung, K. Song, M. Fukumoto, V. E. Gould, and I. Lee
Malgun (Clear) Cell Change in Helicobacter pylori Gastritis Reflects Epithelial Genomic Damage and Repair
Am. J. Pathol.,
April 1, 2003;
162(4):
1203 - 1211.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Matheos, O. Novac, G. B. Price, and M. Zannis-Hadjopoulos
Analysis of the DNA replication competence of the xrs-5 mutant cells defective in Ku86
J. Cell Sci.,
January 1, 2003;
116(1):
111 - 124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. W. Adamson, W.-J. Kim, S. Shangary, R. Baskaran, and K. D. Brown
ATM Is Activated in Response to N-Methyl-N'-nitro- N-nitrosoguanidine-induced DNA Alkylation
J. Biol. Chem.,
October 4, 2002;
277(41):
38222 - 38229.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Koike, T. Shiomi, and A. Koike
Dimerization and Nuclear Localization of Ku Proteins
J. Biol. Chem.,
March 30, 2001;
276(14):
11167 - 11173.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|